Royce & Associates’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-789,227	Closed	-$8.98M	–	912
2024 Q3	$8.98M	Buy	789,227 +57,111	+8%	+$573K	0.08%	339
2024 Q2	$5.23M	Buy	732,116 +93,816	+15%	+$718K	0.05%	470
2024 Q1	$4.28M	Buy	638,300 +140,230	+28%	+$965K	0.04%	529
2023 Q4	$3.24M	Buy	498,070 +220,070	+79%	+$1.42M	0.03%	576
2023 Q3	$2.62M	Sell	278,000 -25,000	-8%	-$301K	0.03%	609
2023 Q2	$4.23M	Hold	303,000	–	–	0.04%	532
2023 Q1	$5.68M	Buy	303,000 +47,000	+18%	+$772K	0.06%	455
2022 Q4	$3.53M	Buy	256,000 +41,600	+19%	+$637K	0.04%	557
2022 Q3	$4.1M	Sell	214,400 -115,300	-35%	-$2.1M	0.05%	487
2022 Q2	$5.03M	Sell	329,700 -48,500	-13%	-$717K	0.05%	472
2022 Q1	$7.7M	Buy	378,200 +189,500	+100%	+$3.86M	0.07%	433
2021 Q4	$5.51M	Sell	188,700 -38,900	-17%	-$1.11M	0.04%	545
2021 Q3	$4.91M	Sell	227,600 -3,400	-1%	-$82.1K	0.04%	587
2021 Q2	$5.92M	Sell	231,000 -44,200	-16%	-$944K	0.04%	569
2021 Q1	$5.02M	Sell	275,200 -3,300	-1%	-$54.8K	0.03%	596
2020 Q4	$3.21M	Buy	278,500 +21,500	+8%	+$197K	0.03%	644
2020 Q3	$1.96M	Hold	257,000	–	–	0.02%	682
2020 Q2	$1.69M	Sell	257,000 -42,000	-14%	-$234K	0.02%	703
2020 Q1	$1.53M	Sell	299,000 -35,000	-10%	-$212K	0.02%	656
2019 Q4	$2.56M	Hold	334,000	–	–	0.02%	648
2019 Q3	$1.77M	Buy	334,000 +34,000	+11%	+$211K	0.02%	728
2019 Q2	$1.68M	Buy	+300,000	New	+$1.24M	0.02%	758